Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (1361-1370 of 1,389) with videos related to

Pageof 139
Sort By:
Medcomm|April 6, 2026
Cancer Neuroscience: Innovative Conception and Emerging Strategy of TherapyTing Wang, Zikai Dong, Yongfei Wang, et al.
Medcomm|April 6, 2026
Cerebral Infarction: Epidemiology, Classification, Mechanisms, Diagnosis, and ManagementMeibiao Zhang, Jianxun Hou, Jia Kuang, et al.
Medcomm|April 13, 2026
Oncolytic Therapy: Delivery System and New Therapeutic Strategies for CancerSikan Jin, Yi Zhang, Ziling Zhou, et al.
Medcomm|April 23, 2026
Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II StudyTing Zhou, Haishuang Sun, Gang Chen, et al.
Medcomm|April 8, 2026
Systematic Proteomic Characterization of EV-A71-Infected Mice Identifies Dynamic Molecular Changes and Therapeutic TargetsWanjun Peng, Qiaochu Wang, Binbin Zhao, et al.
Medcomm|April 8, 2026
Peripheral Blood Mononuclear Cells Profiling Revealed Biomarkers That Predict PD-1 Inhibitor-Induced Immune-Related Adverse EventsJun Wang, Hong Xie, Yuanyuan Gong, et al.
Medcomm|April 3, 2026
Mini-Catalytically Inactive Cas13X-Derived RNA Base Editing of β-Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury ModelWenyi Liu, Wanda Bi, Saiying Hou, et al.
Medcomm|April 3, 2026
Chromatin Accessibility in Cancer: Biological Functions, Mechanisms, Therapeutic Potential, and Future DirectionsWentao Xia, Min Jiang, Yefei Huang, et al.
Medcomm|April 3, 2026
PRMT5 Methylates and Stabilizes EphA2 via Inhibiting Its Ubiquitination and Degradation to Promote Nasopharyngeal Carcinoma Stem Cell PropertiesZheng-Zheng Yu, Xue-Li Mao, Shan-Shan Lu, et al.
Medcomm|April 3, 2026
Nanobody-Mediated c-MYC Degradation Inhibits Tumor Cell ProgressionYuanyuan Xue, Hao Jiang, Zhaoyun Zong, et al.
Pageof 139

Showing results (1361-1370 of 1,389) with videos related to

Sort By:
Pageof 139
Medcomm|April 6, 2026
Cancer Neuroscience: Innovative Conception and Emerging Strategy of TherapyTing Wang, Zikai Dong, Yongfei Wang, et al.
Medcomm|April 6, 2026
Cerebral Infarction: Epidemiology, Classification, Mechanisms, Diagnosis, and ManagementMeibiao Zhang, Jianxun Hou, Jia Kuang, et al.
Medcomm|April 13, 2026
Oncolytic Therapy: Delivery System and New Therapeutic Strategies for CancerSikan Jin, Yi Zhang, Ziling Zhou, et al.
Medcomm|April 23, 2026
Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II StudyTing Zhou, Haishuang Sun, Gang Chen, et al.
Medcomm|April 8, 2026
Systematic Proteomic Characterization of EV-A71-Infected Mice Identifies Dynamic Molecular Changes and Therapeutic TargetsWanjun Peng, Qiaochu Wang, Binbin Zhao, et al.
Medcomm|April 8, 2026
Peripheral Blood Mononuclear Cells Profiling Revealed Biomarkers That Predict PD-1 Inhibitor-Induced Immune-Related Adverse EventsJun Wang, Hong Xie, Yuanyuan Gong, et al.
Medcomm|April 3, 2026
Mini-Catalytically Inactive Cas13X-Derived RNA Base Editing of β-Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury ModelWenyi Liu, Wanda Bi, Saiying Hou, et al.
Medcomm|April 3, 2026
Chromatin Accessibility in Cancer: Biological Functions, Mechanisms, Therapeutic Potential, and Future DirectionsWentao Xia, Min Jiang, Yefei Huang, et al.
Medcomm|April 3, 2026
PRMT5 Methylates and Stabilizes EphA2 via Inhibiting Its Ubiquitination and Degradation to Promote Nasopharyngeal Carcinoma Stem Cell PropertiesZheng-Zheng Yu, Xue-Li Mao, Shan-Shan Lu, et al.
Medcomm|April 3, 2026
Nanobody-Mediated c-MYC Degradation Inhibits Tumor Cell ProgressionYuanyuan Xue, Hao Jiang, Zhaoyun Zong, et al.
Pageof 139